About FDA
Number of drugs Advisory Committee meetings held that month
Dictionary: Number of CDER advisory committees meetings held is the number of meetings that took place for the month and is related to the Federal Register (FR) notices. For example, on March 7th, 2010, the committee will discuss New Drug Application (NDA) 123123 in the morning and NDA 321321 in the afternoon. If two separate FR notices have been put out, then that counts as two meetings. If the same meeting occurred, but only one FR notice was put out, then it would count as one meeting.
This measure has been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 2 |
| Nov 2010 | N/A | 5 |
| Dec 2010 | N/A | 4 |
| Jan 2011 | N/A | 2 |
| Feb 2011 | N/A | 1 |
| Mar 2011 | N/A | 4 |
| Apr 2011 | N/A | 4 |
| May 2011 | N/A | 3 |
| Jun 2011 | N/A | 3 |
| Jul 2011 | N/A | 6 |
| Aug 2011 | N/A | 0 |
| Sep 2011 | N/A | 3 |
FY 2011 Total: 37
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
